Overview

An agonist is a molecule that binds to a biological receptor and triggers the receptor's active state, producing a cellular or physiological response. In pharmacology the term covers natural signaling substances (such as hormones and neurotransmitters) as well as synthetic compounds. Agonists are a subset of ligands and act at specific protein targets often described simply as a receptor.

Key characteristics

Two general properties describe how an agonist behaves: its affinity (how tightly it binds the receptor) and its efficacy (how well it activates the receptor once bound). Related concepts include potency (the concentration required to produce an effect) and selectivity (preference for particular receptor subtypes).

  • Full agonists can produce the maximum possible response of a receptor system.
  • Partial agonists activate receptors but only produce a submaximal response even at full occupancy.
  • Allosteric agonists bind at sites distinct from the main (orthosteric) site and modulate activity.

Types, mechanisms and history

Beyond direct binding, some agents act indirectly by increasing the concentration of an endogenous agonist (for example, promoting release or blocking reuptake). The agonist concept developed alongside receptor theory in 20th-century pharmacology and has been refined as molecular biology clarified receptor structures and signaling pathways.

Uses and importance

Agonists are central to physiology and medicine. Endogenous agonists mediate normal functions, while therapeutic agonists can restore or modify signaling in disease. Agonists are tools in research for probing receptor function, mapping tissue expression, and screening for new drugs that alter signaling pathways that contribute to health and disease.

Distinctions and notable facts

Agonists differ from antagonists, which occupy receptors without activating them and thereby block agonist action. Inverse agonists reduce a receptor's constitutive activity, producing effects opposite to those of an agonist. In complex systems a partial agonist can behave as an antagonist in the presence of a full agonist. Proper agonist design balances affinity, efficacy, selectivity and safety to support therapeutic goals and maintain homeostasis.

Practical considerations

In clinical and experimental contexts, dose, delivery route and receptor expression influence an agonist's effect. Repeated exposure may produce tolerance or receptor desensitization, which are important when using agonists therapeutically or interpreting experimental results.